Trial By Error: A Commercial Deal for King’s College London’s IBS-CBT Digital Program

By David Tuller, DrPH On January 10th, the following information was announced in a press release: Mahana Therapeutics, a digital therapeutics company reimagining the treatment of chronic diseases, today announced that the Company has entered into a licensing and collaboration agreement with King’s College London, a leading research university and one of the oldest and […]

Source link

Related posts

Domestication of High-Copy Transposons Underlays the Wheat Small RNA Response to an Obligate Pathogen


Anabolic SIRT4 Exerts Retrograde Control over TORC1 Signaling by Glutamine Sparing in the Mitochondria [Research Article]


Senior Research Technician in the Panfilio Lab, University of Warwick, UK


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy